BROMOCRIPTINE MESYLATE (bromocriptine mesylate) by Aurobindo Pharma is mesylate, a sympatholytic, dopamine d2 receptor agonist. Approved for type 2 diabetes mellitus, type 1 diabetes, diabetic ketoacidosis. First approved in 1998.
Drug data last refreshed 20h ago
mesylate, a sympatholytic, dopamine D2 receptor agonist. In patients with type 2 diabetes, timed morning administration of CYCLOSET is associated with increased insulin sensitivity and glucose disposal and reduced fasting and postprandial hyperglycemia throughout the meals of the day without…
Worked on BROMOCRIPTINE MESYLATE at Aurobindo Pharma? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.